Liu Tian, Xu Chen, Chen Hangjun, Chen Fuhua, Feng Bei, Tao Xiaoying, Zhou Yibo
Department of Ultrasound, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Front Oncol. 2025 May 26;15:1469167. doi: 10.3389/fonc.2025.1469167. eCollection 2025.
Anaplastic thyroid cancer (ATC) is a rare but highly aggressive tumor of the thyroid. Due to its rapid progression and resistance to radiotherapy, the prognosis of ATC is poor. Novel treatments have been increasingly applied in recent years, but the outcome of treatment is not satisfactory.
We present a case of advanced ATC that cannot be surgically resected, who underwent ultrasound-guided radiofrequency ablation (RFA) combined with immunotherapy and targeted therapy for tumor shrinkage. The patient's symptoms, including neck pain, were significantly relieved, and the follow-up of this patient showed a satisfactory outcome with no associated complications. To the best of our knowledge, this is the first case of palliative treatment by RFA in a patient with advanced ATC. It exemplifies a new application and success of this classical approach in palliative treatment.
This case indicates that RFA has a good therapeutic effect on elderly patients with advanced ATC. Such an approach will provide new ideas for the treatment of advanced ATC and warrants further study in the future.
间变性甲状腺癌(ATC)是一种罕见但侵袭性很强的甲状腺肿瘤。由于其进展迅速且对放疗耐药,ATC的预后很差。近年来新型治疗方法已越来越多地被应用,但治疗效果并不令人满意。
我们报告一例无法手术切除的晚期ATC病例,该患者接受了超声引导下射频消融(RFA)联合免疫治疗和靶向治疗以缩小肿瘤。患者的症状,包括颈部疼痛,得到了显著缓解,对该患者的随访显示结果令人满意且无相关并发症。据我们所知,这是首例对晚期ATC患者采用RFA进行姑息治疗的病例。它例证了这种经典方法在姑息治疗中的新应用及成功。
该病例表明RFA对老年晚期ATC患者有良好的治疗效果。这种方法将为晚期ATC的治疗提供新思路,值得未来进一步研究。